These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30655858)

  • 21. Differences of time-dependent microRNA expressions in breast cancer cells.
    Bozkurt SB; Ozturk B; Kocak N; Unlu A
    Noncoding RNA Res; 2021 Mar; 6(1):15-22. PubMed ID: 33385103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
    Chen F; Luo N; Hu Y; Li X; Zhang K
    Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
    Li G; Yang M; Zuo L; Wang MX
    Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells.
    Shuaib M; Kumar S
    Pathol Res Pract; 2024 Jan; 253():155017. PubMed ID: 38101160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB
    Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
    Liu H; Wang G
    Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
    Shuaib M; Chaudhri S; Kumar S
    Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
    Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gold nanoparticles attenuate the interferon-γ induced SOCS1 expression and activation of NF-κB p65/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells.
    Farhana A; Alsrhani A; Rasheed N; Rasheed Z
    Front Immunol; 2023; 14():1228458. PubMed ID: 37720228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN.
    Fang H; Xie J; Zhang M; Zhao Z; Wan Y; Yao Y
    Am J Transl Res; 2017; 9(3):953-961. PubMed ID: 28386324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Noncoding RNA
    Tang L; Chen Y; Tang X; Wei D; Xu X; Yan F
    J Cancer; 2020; 11(2):311-323. PubMed ID: 31897227
    [No Abstract]   [Full Text] [Related]  

  • 33. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.
    Li D; Wang H; Song H; Xu H; Zhao B; Wu C; Hu J; Wu T; Xie D; Zhao J; Shen Q; Fang L
    Oncotarget; 2017 Oct; 8(49):85276-85289. PubMed ID: 29156719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
    Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
    Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1.
    Li Y; Hua K; Jin J; Fang L
    Oncol Lett; 2021 Aug; 22(2):580. PubMed ID: 34122631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
    Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
    Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Steroidal Lactone Induces G1/S Phase Cell Cycle Arrest and Intrinsic Apoptotic Pathway by Up-Regulating Tumor Suppressive miRNA in Triple-Negative Breast Cancer Cells.
    Shuaib M; Prajapati KS; Gupta S; Kumar S
    Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
    Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
    Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells.
    Wang Q; Li C; Zhu Z; Teng Y; Che X; Wang Y; Ma Y; Wang Y; Zheng H; Liu Y; Qu X
    Anticancer Drugs; 2016 Jan; 27(1):9-16. PubMed ID: 26398931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-6838-5p suppresses cell metastasis and the EMT process in triple-negative breast cancer by targeting WNT3A to inhibit the Wnt pathway.
    Liu G; Wang P; Zhang H
    J Gene Med; 2019 Dec; 21(12):e3129. PubMed ID: 31693779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.